期刊文献+

肾脏中性粒细胞明胶酶相关脂质运载蛋白的表达与肝硬化时肾功能的关系

Correlation between kidney expression of neutrophil gelatinase-associated lipocalin and renal function impairment in liver cirrhosis
下载PDF
导出
摘要 目的观察肝硬化模型中肾脏中性粒细胞明胶酶相关脂质运载蛋白(NGAL)表达与肾功能受损之间的关系。方法选择60只SD雄性大鼠,其中27大鼠在建模过程中死亡,5只SD雄性大鼠作为空白对照,28只SD雄性大鼠经持续服用四氯化碳诱导形成肝硬化腹水模型,按照免疫组化检测肾脏表达NGAL的强度和阳性细胞数建立不同级别组:低度表达组,中度表达组,高度表达组,极高表达组。Western blot测定各组NGAL的表达,并通过检测蛋白条带的光密度值进行半定量分析。通过全自动生化分析仪测定肌酐(Cr)及尿素氮(BUN)。结果 28只大鼠出现肝硬化腹水,Western blot半定量检测发现各组之间差异有统计学意义(P<0.05),极高表达组表达量最高,而高度表达组、中度表达组、低度表达组表达量依次降低;肾脏NGAL的表达越强,大鼠血中BUN、Cr升高的越多,且差异有统计学意义(P<0.05)。肾脏NGAL表达主要分布在近曲肾小管及远端肾单位。结论在肝硬化腹水肾脏功能损伤时,肾脏NGAL主要分布于近曲肾小管及远端肾单位,且其表达提示肾脏损伤程度。 Objective To observe the relationship between kidney expression of neutrophil gelatinase-associated lipocalin (NGAL) and renal function in a rat liver cirrhosis model.Methods A total of 60 male Sprague Dawley (SD)rats were included in this experiment.27 rats were died during the process of model building,5 male SD rats were used as control,28 male SD rats were induced into liver cirrhosis with ascites through periodic carbon tetrachloride intragastric administration.Different groups such as slight staining group,moderate staining group,intense staining group,highly intense staining group were divided according to the NGAL expression intensity and NGAL positive cell number detected by immunohistochemistry.Then the protein expression of NGAL was further examined by Western blot and semi-quantified by densitometry.Automatic biochemistry analyzer was employed to measure blood urea nitrogen (BUN)and serum Creatinine (Cr).Results 28 animals with cirrhosis developed ascites.Western blot analysis revealed that there were significant differences among those different groups (P < 0.05).The expression of NGAL in highly intense staining group was highest.The expression of NGAL was stepwise decreased from intense staining group to moderate staining group and slight staining group.BUN,Cr levels in blood elevated as NGAL expression in kidney increased (P <0.05).Furthermore,NGAL distributed primarily in proximal tubules and distal nephron segments in these groups.Conclusion In the rat liver cirrhosis model with impaired renal function,NGAL primarily distributes in proximal tubules and distal nephron segments.The NGAL staining intensity is correlated with the degree of renal function impairment.
出处 《中国医药导报》 CAS 2014年第9期17-19,25,共4页 China Medical Herald
关键词 肝硬化模型 肾功能受损 中性粒细胞明胶酶相关脂质运载蛋白 肾脏 Liver cirrhosis model Renal function impairment Neutrophil gelatinase-associated lipocalin Kidney
  • 相关文献

参考文献13

  • 1Goetz DH, Holmes MA, Borregaard N, et al. The neu- trophil lipocalin NGAL is a bacteriostatic agent that in- terferes with siderophore-mediated iron acquisition [J]. Mol Cell ,2002, 10(5) : 1033-1043.
  • 2Mishra J, Mori K, Ma Q, et al. Neutrophil gelatinase-as- sociated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity [J]. Am J Nephrol,2004,24 (3) : 307-315.
  • 3Mishra J, Ma Q, Prada A, et al. Identification of neu- trophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury [J]. J Am Soe Nephrol, 2003,14 (10) : 2534-2543.
  • 4Mishra J, Ma Q, Kelly C, et al. Kidney NGAL is a novel early marker of acute injury following transplantation [J]. Pediatr Neohrol. 2006.21 (6 : 856-863.
  • 5Gerbes AL, Benesic A, Vogeser M, et al. Serum Neu- trophil Gelatinase-Associated Lipocalin-A Sensitive Novel Marker of Renal Impairment in Liver Cirrhosis?[J]. Diges- tion, 2011,84(1) : 82-83.
  • 6Cavallin M, Fasolato S, Sticca A, et al. Increased uri- nary level of neutrophil gelatinase-associated lipocalin (NGAL) in patients with cirrhosis and type 1 HRS[J]. Hepatology, 2011,54 (Suppl 4 ) : 1254-1255.
  • 7Guarner C, Runyon BA, Young S, et al. Intestinal bacte- rial overgrowth and bacterial translocation in cirrhotic rats with ascites [J]. J Hepatol, 1997,26(6):1372-1378.
  • 8Sun Y, Yokoi K, Li H, et al. NGAL expression is elevat- ed in both colorectal adenoma-carcinoma Sequence and cancer progression and enhances tumorigenesis in xenograft mouse models [J]. Clin Cancer Res,2011,17 ( 13 ) : 4331-4340.
  • 9王宇明,朱鹏.终末期肝病中的急性肾损伤与肝肾综合征[J].中华肝脏病杂志,2013,21(3):173-176. 被引量:23
  • 10Fagundes C, P6pin MN, Guevara M, et al. Urinary neu- trophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney func- tion in cirrhosis [J]. J Hepatol, 2012,57 (2) : 267-273.

二级参考文献16

  • 1Garcia-Tsao G, Parikh CR, Viola A. Acute kidney injury in cirrhosis. Hepatology, 2008, 48: 2064-2077.
  • 2European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol, 2010, 53: 397-417.
  • 3Wadei HM. Hepatorenal syndrome: a critical update. Semin Respir Crit Care Meal, 2012, 33: 55-69.
  • 4Glassford NJ, BeUomo R. Acute kidney injury: how can we facilitate recovery? Curr Opin Crit Care, 2011, 17: 562-568.
  • 5Lata J. Hepatorenal syndrome. World J Gastroenterol, 2012, 18: 4978-4984.
  • 6Arroyo V, Fernandez J. Management of hepatorenal syndrome in patints with cirrhosis. Nat Rev Nephrol, 2011, 7: 517-526.
  • 7Boyer TD, Sanyal AJ, Garcia-Tsao G, et al. Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamies. J Hepatol, 2011, 55: 315-321.
  • 8Gluud LL, Christensen K, Christensen E, et al. Terlipressin for hepatorenal syndrome. Coehrane Database Syst Rev, 2012, 9: CD005162.
  • 9Singh V, Ghosh S, Singh B, et al. Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study. J Hepatol, 2012, 56: 1293-1298.
  • 10Fagundes C, Gin,s P. Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis. Am J Kidney Dis, 2012, 59: 874- 885.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部